ペンシルベニアにおける骨髄異形成症候群の臨床試験
ペンシルベニア内の拠点で、骨髄異形成症候群に関する17件の研究が参加者を募集しています。
ペンシルベニア内の都市
公式研究テキスト（英語）
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
- Geisinger Medical Center, Danville
- UPMC Hillman Cancer Center, Pittsburgh
- Geisinger Wyoming Valley/Henry Cancer Center, Wilkes-Barre
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06577441MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
- Lehigh Valley Hospital-Cedar Crest, Allentown
- Geisinger Medical Center, Danville
- Penn State Milton S Hershey Medical Center, Hershey
- 他6件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/25更新 · NCT05564390Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
- University of Pennsylvania, Philadelphia
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/23更新 · NCT05320198A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
- Thomas Jefferson University, Philadelphia
- Fox Chase Cancer Center, Philadelphia
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/18更新 · NCT07422480Collection of Tissue Samples for Cancer Research
- University of Pittsburgh Medical Center, Pittsburgh
被験者募集中観察研究
2 Months · 全性別 · 2026/09/16更新 · NCT00900198A Study of BGB-11417 in Participants With Myeloid Malignancies
- Upmc Hillman Cancer Center(Univ of Pittsburgh), Pittsburgh
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/14更新 · NCT04771130Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS
- UPENN Perelman Center for Advanced Medicine, Philadelphia
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/14更新 · NCT06846606The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Lehigh Valley Hospital-Cedar Crest, Allentown
- Geisinger Medical Center, Danville
- Penn State Children's Hospital, Hershey
- 他3件
被験者募集中第1/2相
22歳以下 · 全性別 · 2026/08/25更新 · NCT04726241Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies
- UMPC Hillman Cancer Center, Pittsburgh
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/18更新 · NCT07565220Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell Transplantation
- UPMC Hillman Cancer Center, Pittsburgh
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/11更新 · NCT06529731CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT
- Children's Hospital of Philadelphia, Philadelphia
被験者募集中
25歳以下 · 全性別 · 2026/07/08更新 · NCT03810196A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Sidney Kimmel Comprehensive Cancer Center, Philadelphia
- Allegheny Health Network, Pittsburgh
被験者募集中第1/2相
12歳以上 · 全性別 · 2026/03/24更新 · NCT04988555Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)
- University of Pittsburgh Cancer Institute (UPCI), Pittsburgh
被験者募集中第2相
1歳〜60歳 · 全性別 · 2026/03/12更新 · NCT03970096Home Blood Transfusions
- Thomas Jefferson University Hospital, Philadelphia
被験者募集中
18歳以上 · 全性別 · 2025/12/16更新 · NCT07121140Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors
- Children's Hospital of Philadelphia, Philadelphia
被験者募集中第2相
10歳〜30歳 · 全性別 · 2025/12/04更新 · NCT05194397Two Step Haplo With Radiation Conditioning
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadephia
被験者募集中第2相
18歳以上 · 全性別 · 2025/10/30更新 · NCT05031897SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Philadelphia
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。